Activity of alemtuzumab in patients with CD52-positive acute leukemia.
Tibes R, Keating MJ, Ferrajoli A, Wierda W, Ravandi F, Garcia-Manero G, O'Brien S, Cortes J, Verstovsek S, Browning ML, Faderl S.
Tibes R, et al. Among authors: ravandi f.
Cancer. 2006 Jun 15;106(12):2645-51. doi: 10.1002/cncr.21901.
Cancer. 2006.
PMID: 16688777
Free article.
Clinical Trial.